173 related articles for article (PubMed ID: 12432243)
21. HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter.
Deng L; Ammosova T; Pumfery A; Kashanchi F; Nekhai S
J Biol Chem; 2002 Sep; 277(37):33922-9. PubMed ID: 12114499
[TBL] [Abstract][Full Text] [Related]
22. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription.
Fu TJ; Peng J; Lee G; Price DH; Flores O
J Biol Chem; 1999 Dec; 274(49):34527-30. PubMed ID: 10574912
[TBL] [Abstract][Full Text] [Related]
23. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
Fujinaga K; Irwin D; Geyer M; Peterlin BM
J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
[TBL] [Abstract][Full Text] [Related]
24. Role of the cyclin-dependent kinase 9-related pathway in mammalian gene expression and human diseases.
Romano G; Giordano A
Cell Cycle; 2008 Dec; 7(23):3664-8. PubMed ID: 19029809
[TBL] [Abstract][Full Text] [Related]
25. Identification of multiple cyclin subunits of human P-TEFb.
Peng J; Zhu Y; Milton JT; Price DH
Genes Dev; 1998 Mar; 12(5):755-62. PubMed ID: 9499409
[TBL] [Abstract][Full Text] [Related]
26. Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells.
Darbinian N; Sawaya BE; Khalili K; Jaffe N; Wortman B; Giordano A; Amini S
J Neuroimmunol; 2001 Dec; 121(1-2):3-11. PubMed ID: 11730934
[TBL] [Abstract][Full Text] [Related]
27. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
Rice AP
Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507
[TBL] [Abstract][Full Text] [Related]
28. Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines.
Falco GD; Neri LM; Falco MD; Bellan C; Yu Z; Luca AD; Leoncini L; Giordano A
Oncogene; 2002 Oct; 21(49):7464-70. PubMed ID: 12386808
[TBL] [Abstract][Full Text] [Related]
29. Functional inactivation of Cdk9 through oligomerization chain reaction.
Napolitano G; Mazzocco A; Fraldi A; Majello B; Lania L
Oncogene; 2003 Jul; 22(31):4882-8. PubMed ID: 12894230
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo.
Majello B; Napolitano G; Giordano A; Lania L
Oncogene; 1999 Aug; 18(32):4598-605. PubMed ID: 10467404
[TBL] [Abstract][Full Text] [Related]
31. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
Zhou Q; Chen D; Pierstorff E; Luo K
EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
[TBL] [Abstract][Full Text] [Related]
32. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
33. Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.
Ammosova T; Washington K; Debebe Z; Brady J; Nekhai S
Retrovirology; 2005 Jul; 2():47. PubMed ID: 16048649
[TBL] [Abstract][Full Text] [Related]
34. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.
Zhou M; Huang K; Jung KJ; Cho WK; Klase Z; Kashanchi F; Pise-Masison CA; Brady JN
J Virol; 2009 Jan; 83(2):1036-44. PubMed ID: 18971272
[TBL] [Abstract][Full Text] [Related]
35. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions.
Herrmann CH; Mancini MA
J Cell Sci; 2001 Apr; 114(Pt 8):1491-503. PubMed ID: 11282025
[TBL] [Abstract][Full Text] [Related]
36. Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
Devaiah BN; Singer DS
J Biol Chem; 2012 Nov; 287(46):38755-66. PubMed ID: 23027873
[TBL] [Abstract][Full Text] [Related]
37. The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.
Paparidis NF; Durvale MC; Canduri F
Mol Biosyst; 2017 Jan; 13(2):246-276. PubMed ID: 27833949
[TBL] [Abstract][Full Text] [Related]
38. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.
Zhou M; Deng L; Lacoste V; Park HU; Pumfery A; Kashanchi F; Brady JN; Kumar A
J Virol; 2004 Dec; 78(24):13522-33. PubMed ID: 15564463
[TBL] [Abstract][Full Text] [Related]
39. Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors.
De Falco G; Bellan C; D'Amuri A; Angeloni G; Leucci E; Giordano A; Leoncini L
Cancer Biol Ther; 2005 Mar; 4(3):277-81. PubMed ID: 15753651
[TBL] [Abstract][Full Text] [Related]
40. CDK9 a potential target for drug development.
Canduri F; Perez PC; Caceres RA; de Azevedo WF
Med Chem; 2008 May; 4(3):210-8. PubMed ID: 18473913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
